File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Rapid complete remission in multiple myeloma with bortezomib/thalidomide/ dexamethasone combination therapy following development of tumor lysis syndrome

TitleRapid complete remission in multiple myeloma with bortezomib/thalidomide/ dexamethasone combination therapy following development of tumor lysis syndrome
Authors
Chim, CS
Issue Date2008
PublisherSpringer. The Journal's web site is located at http://www.springer.com/medicine/oncology/journal/280
Citation
Cancer Chemotherapy And Pharmacology, 2008, v. 62 n. 1, p. 181-182 How to Cite?
DOI: http://dx.doi.org/10.1007/s00280-007-0574-9
Persistent Identifierhttp://hdl.handle.net/10722/163160
ISSN
0344-5704
2021 Impact Factor: 3.288
2020 SCImago Journal Rankings: 1.112
ISI Accession Number ID
WOS:000254956300020
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorChim, CSen_US
dc.date.accessioned2012-09-05T05:28:16Z-
dc.date.available2012-09-05T05:28:16Z-
dc.date.issued2008en_US
dc.identifier.citationCancer Chemotherapy And Pharmacology, 2008, v. 62 n. 1, p. 181-182en_US
dc.identifier.issn0344-5704en_US
dc.identifier.urihttp://hdl.handle.net/10722/163160-
dc.languageengen_US
dc.publisherSpringer. The Journal's web site is located at http://www.springer.com/medicine/oncology/journal/280en_US
dc.relation.ispartofCancer Chemotherapy and Pharmacologyen_US
dc.subject.meshAntineoplastic Agents - Administration & Dosageen_US
dc.subject.meshAntineoplastic Agents, Hormonal - Administration & Dosageen_US
dc.subject.meshAntineoplastic Combined Chemotherapy Protocols - Adverse Effects - Therapeutic Useen_US
dc.subject.meshBoronic Acids - Administration & Dosageen_US
dc.subject.meshDexamethasone - Administration & Dosageen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshL-Lactate Dehydrogenase - Blooden_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshMultiple Myeloma - Complications - Drug Therapyen_US
dc.subject.meshPyrazines - Administration & Dosageen_US
dc.subject.meshThalidomide - Administration & Dosageen_US
dc.subject.meshTumor Lysis Syndrome - Complicationsen_US
dc.titleRapid complete remission in multiple myeloma with bortezomib/thalidomide/ dexamethasone combination therapy following development of tumor lysis syndromeen_US
dc.typeArticleen_US
dc.identifier.emailChim, CS:jcschim@hku.hken_US
dc.identifier.authorityChim, CS=rp00408en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1007/s00280-007-0574-9en_US
dc.identifier.pmid17846773-
dc.identifier.scopuseid_2-s2.0-42149137393en_US
dc.identifier.hkuros150425-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-42149137393&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume62en_US
dc.identifier.issue1en_US
dc.identifier.spage181en_US
dc.identifier.epage182en_US
dc.identifier.isiWOS:000254956300020-
dc.publisher.placeGermanyen_US
dc.identifier.scopusauthoridChim, CS=7004597253en_US
dc.identifier.citeulike2803844-
dc.identifier.issnl0344-5704-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats